The Fellow on Call: The Heme/Onc Podcast cover image

Episode 076: Management of primary refractory diffuse large B-cell lymphoma (DLBCL)

The Fellow on Call: The Heme/Onc Podcast

00:00

Managing Primary Refractory DLBCL

This chapter examines the evaluation and treatment strategies for patients with primary refractory diffuse large B-cell lymphoma (DLBCL). It highlights the significance of patient assessment for curative therapies like CAR-T and looks at various chemotherapy regimens and their response rates. The discussion also addresses the historical context of treatments, the current landscape of CAR-T therapies, and the challenges in managing patient care effectively.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app